October 8, 2020
NCCN Guidelines for Patients: Pediatric ALL BookmarkGeorge Lundberg, MD
PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Pediatric Acute Lymphoblastic Leukemia.
August 17, 2019
Acute Lymphoblastic Leukemia (ALL)—An Overview BookmarkGeorge Lundberg, MD
Curated by Editor in Chief George Lundberg, MD, who notes:
Acute lymphoblastic leukemia (also known as childhood leukemia) is a serious but often treatable form of leukemia. This authoritative presentation from Medscape is recent, trustworthy, and comprehensive.
September 6, 2017
A Cancer Doctor Weighs In On CAR-T, Precision Medicine And Pricing Debates BookmarkEmma Shtivelman, PhD
“Yesterday’s historic FDA approval of the first engineered T-cell treatment for cancer, Novartis’ Kymriah (tisagenlecleucel), was accompanied by inevitable questions about how the product would be priced. In the end, Novartis set the price at $475,000, which was lower than many analysts had predicted, considering the treatment is designed to cure some forms of acute lymphoblastic leukemia (ALL)—and in clinical trials it did just that for most patients.”
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.